Seattle Washington based Silverback Therapeutics is raising $78,697,259.00 in New Equity Investment.
Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Silverback Therapeutics is raising $78,697,259.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Peter Thompson played a…